Abstract
Purpose. To investigate the behaviour of peptides and hyaluronan in strong acid solutions containing electrolytes in the preparation of a new formulation of insulin, hyaluronan-insulin complex, and to evaluate the in vivo oral activity of the formulation.
Methods. Individual processing parameters in the preparation of the insulin complex were first refined, and two formulations were subsequently investigated. The chemical structure, particle size and hydrophilic/hydrophobic properties of the insulin complex in these formulations were studied using light scattering techniques, amino acid analysis, atomic force microscopy and cryo-transmission electron microscopy. The in vivo activity of oral hyaluronan-insulin complex was then evaluated by measuring the decrease in blood glucose concentrations in streptozotocin diabetic rats.
Results. Five of seven batches of the two insulin complex formulations fit the baseline criteria for approval of the new formulation. The formulation consists of a transparent aqua sol containing a solid hydrophobic phase as precipitate. Glucose-lowering activity was demonstrated after oral administration of the insulin complex to diabetic rats.
Conclusion. A new insulin formulation, a hyaluronan-insulin complex, has been developed and oral activity has been demonstrated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
O. Pillai and R. Panchagnula. Insulin therapies—past, present and future. Drug Discov. Today 6:1056–1061 (2001).
M. A. Clark, M. A. Jepson, and B. H. Hirst. Exploiting Mcells for drug and vaccine delivery. Adv. Drug Deliv. Rev. 50:81–106 (2001).
B. Furugren. Biomolecules Studied by Small-Angle X-ray Scattering. Swedish University of Agricultural Sciences, Uppsala, 1987.
G. Jederstrom and G. Russell. Size exclusion chromatography of liposomes on different gel media. J. Pharm. Sci. 70:874–878 (1981).
S. Friberg, L. Rydhag, and G. Jederstrom. Liquid crystalline phases in aerosol formulations. I. Phase equilibria in propellant compositions. J. Pharm. Sci. 60:1883–1885 (1971).
G. Jederstrom, L. Rydhag, and S. Friberg. Liquid crystalline phases in aerosol formation. II. Influence of liquid crystalline phases on foam stability. J. Pharm. Sci. 62:1979–1982 (1973).
K. Thalberg. Polyelectrolyte–Surfactant Interactions. Division of Physical Chemistry 1. Chemical Center, University of Lund, Lund, 1990, pp.180.
W. D. Comper and T. C. Laurent. Physiological function of connective tissue polysaccharides. Physiol. Rev. 58:255–315 (1978).
T. C. Laurent. Biochemistry of hyaluronan. Acta Oto-Laryngo-logica. Suppl. 442:7–24 (1987).
D. Miller and R. Stegman (eds.). Healon (Sodium Hyaluronate): A Guide To its Use in Ophthalmic Surgery. Wiley, New York, 1983.
G. Jederstrom, J. Gråsjö, A. Nordin, I. Sjöholm, and A. Andersson. Efficacy of oral hyaluronan-insulin complex in diabetes rats. Diabetologia (2004).
J. P. Roubroeks, D. I. Mastromauro, R. Andersson, B. E. Christensen, and P. Åman. Molecular weight, structure and shape of oat (1-3),(1-4)-β-d-glucan fractions obtained by enzymatic deg-radation with lichenase. Biomacromolecules 1:584–591 (2000).
R. P. B. Berne. Dynamic Light Scattering. Wiley, New York, 1976.
J. Jakes. Testing of the constrained regularization method of inverting Laplace transform on simulated very wide quasielastic light-scattering auto-correlation function. Czech. J. Phys. B38: 1305–1316 (1988).
M. E. Aulton. Pharmaceutics: The science of dosage form design. 2nd ed. Churchill Livingstone, Edinburgh, London, New York, Philadelphia, St. Louis, Sidney, Toronto, 2002.
G. Jederstrom. Hydrophobe Biomolecular Structure, United States Patent. US 6448093:1–28 (2002).
M. Bergkvist. Orientation and Conformation of Single Macromol-ecules on Unmodified and Functionalized Surfaces. Faculty of Science and Technology, Uppsala Universitet, Uppsala, 2002, pp. 62.
M. Almgren, K. Edwards, and G. Karlsson. Cryo transmission electron microscopy of liposome and related structures. Colloids and Surfaces. A: Physicochemical Engineering Aspects 174:3–21 (2000).
E. D. G. Bentley, G. Dodson, D. Hodgkin, and D. Mercola. Structure of insulin in 4-zinc insulin. Nature 261:166–168 (1976).
H. B. Olsen, S. Ludvigsen, and N. C. Kaarsholm. Solution structure of an engineered insulin monomer at neutral pH. Biochemistry 35:8836–8845 (1996).
U. Derewenda, Z. Derewenda, E. J. Dodson, G. G. Dodson, C. D. Reynolds, G. D. Smith, C. Sparks, and D. Swenson. Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer. Nature 338:594–596 (1989).
J. Brange. Galenics of Insulin. Springer-Verlag, Berlin, Heidel-berg, 1987.
J. B. Honing, K. Sharp, and A.-S. Yang. Macroscopic models of aqueous solutions and chemical applications. J. Phys. Chem. 97: 1101–1109 (1993).
B. V. Derjaguin. I. L. Abricosova and E. M. Lifshitz. Direct measurement of molecular attraction between solids separated by a narrow gap. Q. Rev. Chem. Soc. 10:295–329 (1956).
B. V. Derjaguin. The forces between molecules. Sci. Am. 203:47–53 (1960).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jederstrom, G., Andersson, A., Gråsjö, J. et al. Formulating Insulin for Oral Administration: Preparation of Hyaluronan-Insulin Complex. Pharm Res 21, 2040–2047 (2004). https://doi.org/10.1023/B:PHAM.0000048195.69304.ff
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000048195.69304.ff